-
1
-
-
9144265679
-
Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects
-
Abdollahi A., Lipson K.E., Sckell A., Zieher H., Klenke F., Poerschke D., Roth A., Han X., Krix M., Bischof M., Hahnfeldt P., Grone H.J., Debus J., Hlatky L., and Huber P.E. Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects. Cancer Res. 63 (2003) 8890-8898
-
(2003)
Cancer Res.
, vol.63
, pp. 8890-8898
-
-
Abdollahi, A.1
Lipson, K.E.2
Sckell, A.3
Zieher, H.4
Klenke, F.5
Poerschke, D.6
Roth, A.7
Han, X.8
Krix, M.9
Bischof, M.10
Hahnfeldt, P.11
Grone, H.J.12
Debus, J.13
Hlatky, L.14
Huber, P.E.15
-
2
-
-
4544342570
-
Nuclear factor-kappaB: the enemy within
-
Aggarwal B.B. Nuclear factor-kappaB: the enemy within. Cancer Cell 6 (2004) 203-208
-
(2004)
Cancer Cell
, vol.6
, pp. 203-208
-
-
Aggarwal, B.B.1
-
3
-
-
0031752682
-
Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches
-
Ain K.B. Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches. Thyroid 8 (1998) 715-726
-
(1998)
Thyroid
, vol.8
, pp. 715-726
-
-
Ain, K.B.1
-
4
-
-
0036890831
-
Recent advances in angiogenesis, anti-angiogenesis and vascular targeting
-
Bikfalvi A., and Bicknell R. Recent advances in angiogenesis, anti-angiogenesis and vascular targeting. Trends Pharmacol. Sci. 23 (2002) 576-582
-
(2002)
Trends Pharmacol. Sci.
, vol.23
, pp. 576-582
-
-
Bikfalvi, A.1
Bicknell, R.2
-
5
-
-
0034648765
-
Angiogenesis in cancer and other diseases
-
Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
-
(2000)
Nature
, vol.407
, pp. 249-257
-
-
Carmeliet, P.1
Jain, R.K.2
-
6
-
-
33745944185
-
Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells
-
Carter B.Z., Mak D.H., Schober W.D., McQueen T., Harris D., Estrov Z., Evans R.L., and Andreeff M. Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells. Blood 108 (2006) 630-637
-
(2006)
Blood
, vol.108
, pp. 630-637
-
-
Carter, B.Z.1
Mak, D.H.2
Schober, W.D.3
McQueen, T.4
Harris, D.5
Estrov, Z.6
Evans, R.L.7
Andreeff, M.8
-
7
-
-
30744432619
-
Endothelial cells and VEGF in vascular development
-
Coultas L., Chawengsaksophak K., and Rossant J. Endothelial cells and VEGF in vascular development. Nature 438 (2005) 937-945
-
(2005)
Nature
, vol.438
, pp. 937-945
-
-
Coultas, L.1
Chawengsaksophak, K.2
Rossant, J.3
-
8
-
-
0033597130
-
Endostatin induces endothelial cell apoptosis
-
Dhanabal M., Ramchandran R., Waterman M.J., Lu H., Knebelmann B., Segal M., and Sukhatme V.P. Endostatin induces endothelial cell apoptosis. J. Biol. Chem. 274 (1999) 11721-11726
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 11721-11726
-
-
Dhanabal, M.1
Ramchandran, R.2
Waterman, M.J.3
Lu, H.4
Knebelmann, B.5
Segal, M.6
Sukhatme, V.P.7
-
9
-
-
34047132303
-
Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression
-
Fang J., Zhou Q., Liu L.Z., Xia C., Hu X., Shi X., and Jiang B.H. Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression. Carcinogenesis 28 (2007) 858-864
-
(2007)
Carcinogenesis
, vol.28
, pp. 858-864
-
-
Fang, J.1
Zhou, Q.2
Liu, L.Z.3
Xia, C.4
Hu, X.5
Shi, X.6
Jiang, B.H.7
-
10
-
-
30744449235
-
Angiogenesis as a therapeutic target
-
Ferrara N., and Kerbel R.S. Angiogenesis as a therapeutic target. Nature 438 (2005) 967-974
-
(2005)
Nature
, vol.438
, pp. 967-974
-
-
Ferrara, N.1
Kerbel, R.S.2
-
12
-
-
0036644835
-
Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude mice
-
Goto H., Yano S., Zhang H., Matsumori Y., Ogawa H., Blakey D.C., and Sone S. Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude mice. Cancer Res. 62 (2002) 3711-3715
-
(2002)
Cancer Res.
, vol.62
, pp. 3711-3715
-
-
Goto, H.1
Yano, S.2
Zhang, H.3
Matsumori, Y.4
Ogawa, H.5
Blakey, D.C.6
Sone, S.7
-
13
-
-
0029008895
-
Isolation, purification, and characterization of immunosuppressive compounds from tripterygium: triptolide and tripdiolide
-
Gu W.Z., Chen R., Brandwein S., McAlpine J., and Burres N. Isolation, purification, and characterization of immunosuppressive compounds from tripterygium: triptolide and tripdiolide. Int. J. Immunopharmacol. 17 (1995) 351-356
-
(1995)
Int. J. Immunopharmacol.
, vol.17
, pp. 351-356
-
-
Gu, W.Z.1
Chen, R.2
Brandwein, S.3
McAlpine, J.4
Burres, N.5
-
14
-
-
0043175171
-
Angiostatin(4.5)-mediated apoptosis of vascular endothelial cells
-
Hanford H.A., Wong C.A., Kassan H., Cundiff D.L., Chandel N., Underwood S., Mitchell C.A., and Soff G.A. Angiostatin(4.5)-mediated apoptosis of vascular endothelial cells. Cancer Res. 63 (2003) 4275-4280
-
(2003)
Cancer Res.
, vol.63
, pp. 4275-4280
-
-
Hanford, H.A.1
Wong, C.A.2
Kassan, H.3
Cundiff, D.L.4
Chandel, N.5
Underwood, S.6
Mitchell, C.A.7
Soff, G.A.8
-
15
-
-
73449089468
-
Triptolide functions as a potent angiogenesis inhibitor
-
He M.F., Huang Y.H., Wu L.W., Ge W., Shaw P.C., and But P.P. Triptolide functions as a potent angiogenesis inhibitor. Int. J. Cancer 126 (2010) 266-278
-
(2010)
Int. J. Cancer
, vol.126
, pp. 266-278
-
-
He, M.F.1
Huang, Y.H.2
Wu, L.W.3
Ge, W.4
Shaw, P.C.5
But, P.P.6
-
16
-
-
1642303371
-
Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis
-
Heroult M., Bernard-Pierrot I., Delbe J., Hamma-Kourbali Y., Katsoris P., Barritault D., Papadimitriou E., Plouet J., and Courty J. Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. Oncogene 23 (2004) 1745-1753
-
(2004)
Oncogene
, vol.23
, pp. 1745-1753
-
-
Heroult, M.1
Bernard-Pierrot, I.2
Delbe, J.3
Hamma-Kourbali, Y.4
Katsoris, P.5
Barritault, D.6
Papadimitriou, E.7
Plouet, J.8
Courty, J.9
-
17
-
-
14644440555
-
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis
-
Hicklin D.J., and Ellis L.M. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J. Clin. Oncol. 23 (2005) 1011-1027
-
(2005)
J. Clin. Oncol.
, vol.23
, pp. 1011-1027
-
-
Hicklin, D.J.1
Ellis, L.M.2
-
18
-
-
33846206474
-
Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells
-
Hoffmann S., Rockenstein A., Ramaswamy A., Celik I., Wunderlich A., Lingelbach S., Hofbauer L.C., and Zielke A. Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells. Mol. Cell. Endocrinol. 264 (2007) 74-81
-
(2007)
Mol. Cell. Endocrinol.
, vol.264
, pp. 74-81
-
-
Hoffmann, S.1
Rockenstein, A.2
Ramaswamy, A.3
Celik, I.4
Wunderlich, A.5
Lingelbach, S.6
Hofbauer, L.C.7
Zielke, A.8
-
19
-
-
0033580889
-
Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
-
Holash J., Maisonpierre P.C., Compton D., Boland P., Alexander C.R., Zagzag D., Yancopoulos G.D., and Wiegand S.J. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284 (1999) 1994-1998
-
(1999)
Science
, vol.284
, pp. 1994-1998
-
-
Holash, J.1
Maisonpierre, P.C.2
Compton, D.3
Boland, P.4
Alexander, C.R.5
Zagzag, D.6
Yancopoulos, G.D.7
Wiegand, S.J.8
-
20
-
-
0035849720
-
Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis
-
Huang S., Pettaway C.A., Uehara H., Bucana C.D., and Fidler I.J. Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene 20 (2001) 4188-4197
-
(2001)
Oncogene
, vol.20
, pp. 4188-4197
-
-
Huang, S.1
Pettaway, C.A.2
Uehara, H.3
Bucana, C.D.4
Fidler, I.J.5
-
21
-
-
0034306969
-
Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8
-
Huang S., Robinson J.B., Deguzman A., Bucana C.D., and Fidler I.J. Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res. 60 (2000) 5334-5339
-
(2000)
Cancer Res.
, vol.60
, pp. 5334-5339
-
-
Huang, S.1
Robinson, J.B.2
Deguzman, A.3
Bucana, C.D.4
Fidler, I.J.5
-
23
-
-
85047700175
-
Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells
-
Jiang X.H., Wong B.C., Lin M.C., Zhu G.H., Kung H.F., Jiang S.H., Yang D., and Lam S.K. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells. Oncogene 20 (2001) 8009-8018
-
(2001)
Oncogene
, vol.20
, pp. 8009-8018
-
-
Jiang, X.H.1
Wong, B.C.2
Lin, M.C.3
Zhu, G.H.4
Kung, H.F.5
Jiang, S.H.6
Yang, D.7
Lam, S.K.8
-
24
-
-
34250704834
-
Sorafenib inhibits the angiogenesis and growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice
-
Kim S., Yazici Y.D., Calzada G., Wang Z.Y., Younes M.N., Jasser S.A., El-Naggar A.K., and Myers J.N. Sorafenib inhibits the angiogenesis and growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice. Mol. Cancer Ther. 6 (2007) 1785-1792
-
(2007)
Mol. Cancer Ther.
, vol.6
, pp. 1785-1792
-
-
Kim, S.1
Yazici, Y.D.2
Calzada, G.3
Wang, Z.Y.4
Younes, M.N.5
Jasser, S.A.6
El-Naggar, A.K.7
Myers, J.N.8
-
25
-
-
34248178375
-
Inhibition of angiogenesis and invasion by 3, 3′-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer
-
Kong D., Li Y., Wang Z., Banerjee S., and Sarkar F.H. Inhibition of angiogenesis and invasion by 3, 3′-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer. Cancer Res. 67 (2007) 3310-3319
-
(2007)
Cancer Res.
, vol.67
, pp. 3310-3319
-
-
Kong, D.1
Li, Y.2
Wang, Z.3
Banerjee, S.4
Sarkar, F.H.5
-
26
-
-
0000597684
-
PG490 (triptolide) cooperates with tumor necrosis factor-alpha to induce apoptosis in tumor cells
-
Lee K.Y., Chang W., Qiu D., Kao P.N., and Rosen G.D. PG490 (triptolide) cooperates with tumor necrosis factor-alpha to induce apoptosis in tumor cells. J. Biol. Chem. 274 (1999) 13451-13455
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 13451-13455
-
-
Lee, K.Y.1
Chang, W.2
Qiu, D.3
Kao, P.N.4
Rosen, G.D.5
-
27
-
-
33846903837
-
Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-kappaB pathways
-
Liu Q., Chen T., Chen G., Shu X., Sun A., Ma P., Lu L., and Cao X. Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-kappaB pathways. Mol. Immunol. 44 (2007) 2686-2696
-
(2007)
Mol. Immunol.
, vol.44
, pp. 2686-2696
-
-
Liu, Q.1
Chen, T.2
Chen, G.3
Shu, X.4
Sun, A.5
Ma, P.6
Lu, L.7
Cao, X.8
-
28
-
-
4544260239
-
Angiogenesis in thyroid cancers
-
Luboshitzky R., and Dharan M. Angiogenesis in thyroid cancers. Thyroid 14 (2004) 793-794
-
(2004)
Thyroid
, vol.14
, pp. 793-794
-
-
Luboshitzky, R.1
Dharan, M.2
-
29
-
-
22244441837
-
Angiogenesis in benign and malignant thyroid disease
-
Mitchell J.C., and Parangi S. Angiogenesis in benign and malignant thyroid disease. Thyroid 15 (2005) 494-510
-
(2005)
Thyroid
, vol.15
, pp. 494-510
-
-
Mitchell, J.C.1
Parangi, S.2
-
30
-
-
0037249255
-
Anaplastic thyroid cancer
-
Pasieka J.L. Anaplastic thyroid cancer. Curr. Opin. Oncol. 15 (2003) 78-83
-
(2003)
Curr. Opin. Oncol.
, vol.15
, pp. 78-83
-
-
Pasieka, J.L.1
-
31
-
-
0037393850
-
A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2
-
Qi J.H., Ebrahem Q., Moore N., Murphy G., Claesson-Welsh L., Bond M., Baker A., and Anand-Apte B. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat. Med. 9 (2003) 407-415
-
(2003)
Nat. Med.
, vol.9
, pp. 407-415
-
-
Qi, J.H.1
Ebrahem, Q.2
Moore, N.3
Murphy, G.4
Claesson-Welsh, L.5
Bond, M.6
Baker, A.7
Anand-Apte, B.8
-
32
-
-
0033532177
-
Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation
-
Qiu D., Zhao G., Aoki Y., Shi L., Uyei A., Nazarian S., Ng J.C., and Kao P.N. Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation. J. Biol. Chem. 274 (1999) 13443-13450
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 13443-13450
-
-
Qiu, D.1
Zhao, G.2
Aoki, Y.3
Shi, L.4
Uyei, A.5
Nazarian, S.6
Ng, J.C.7
Kao, P.N.8
-
33
-
-
17044416487
-
The involvement of endothelial progenitor cells in tumor angiogenesis
-
Ribatti D. The involvement of endothelial progenitor cells in tumor angiogenesis. J. Cell. Mol. Med. 8 (2004) 294-300
-
(2004)
J. Cell. Mol. Med.
, vol.8
, pp. 294-300
-
-
Ribatti, D.1
-
34
-
-
0029013774
-
Urokinase-type plasminogen activator (uPA) and its receptor (CD87): a new target in tumor invasion and metastasis
-
Schmitt M., Wilhelm O., Janicke F., Magdolen V., Reuning U., Ohi H., Moniwa N., Kobayashi H., Weidle U., and Graeff H. Urokinase-type plasminogen activator (uPA) and its receptor (CD87): a new target in tumor invasion and metastasis. J. Obstet. Gynaecol. 21 (1995) 151-165
-
(1995)
J. Obstet. Gynaecol.
, vol.21
, pp. 151-165
-
-
Schmitt, M.1
Wilhelm, O.2
Janicke, F.3
Magdolen, V.4
Reuning, U.5
Ohi, H.6
Moniwa, N.7
Kobayashi, H.8
Weidle, U.9
Graeff, H.10
-
35
-
-
0035040127
-
Angiogenesis inhibition in the in vivo antineoplastic effect of manumycin and paclitaxel against anaplastic thyroid carcinoma
-
Xu G., Pan J., Martin C., and Yeung S.C. Angiogenesis inhibition in the in vivo antineoplastic effect of manumycin and paclitaxel against anaplastic thyroid carcinoma. J. Clin. Endocrinol. Metab. 86 (2001) 1769-1777
-
(2001)
J. Clin. Endocrinol. Metab.
, vol.86
, pp. 1769-1777
-
-
Xu, G.1
Pan, J.2
Martin, C.3
Yeung, S.C.4
-
36
-
-
0141576565
-
Triptolide inhibits the growth and metastasis of solid tumors
-
Yang S., Chen J., Guo Z., Xu X.M., Wang L., Pei X.F., Yang J., Underhill C.B., and Zhang L. Triptolide inhibits the growth and metastasis of solid tumors. Mol. Cancer Ther. 2 (2003) 65-72
-
(2003)
Mol. Cancer Ther.
, vol.2
, pp. 65-72
-
-
Yang, S.1
Chen, J.2
Guo, Z.3
Xu, X.M.4
Wang, L.5
Pei, X.F.6
Yang, J.7
Underhill, C.B.8
Zhang, L.9
-
37
-
-
63849258626
-
A small-molecule triptolide suppresses angiogenesis and invasion of human anaplastic thyroid carcinoma cells via down-regulation of the nuclear factor-kappaB pathway
-
Zhu W., Ou Y., Li Y., Xiao R., Shu M., Zhou Y., Xie J., He S., Qiu P., and Yan G. A small-molecule triptolide suppresses angiogenesis and invasion of human anaplastic thyroid carcinoma cells via down-regulation of the nuclear factor-kappaB pathway. Mol. Pharmacol. 75 (2009) 812-819
-
(2009)
Mol. Pharmacol.
, vol.75
, pp. 812-819
-
-
Zhu, W.1
Ou, Y.2
Li, Y.3
Xiao, R.4
Shu, M.5
Zhou, Y.6
Xie, J.7
He, S.8
Qiu, P.9
Yan, G.10
|